Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04987099 · ClinicalTrials.gov registry record · NA
Effects of Increased Maternal Choline Intake on Child Cognitive Development
A NA study of Pregnancy, sponsored by Cornell University.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04987099: Active NA study of Pregnancy, sponsored by Cornell University.
NCT04987099 is a NA study of Pregnancy that is active but no longer recruiting, run by Cornell University. The registered enrollment target is 40 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04987099, a NA study of Pregnancy, is active but no longer recruiting, sponsored by Cornell University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine cognitive and affective outcomes in the offspring of women supplemented with choline vs. control during pregnancy.
Primary Outcome
The composite novelty score (proportion of looking to the novel image) is obtained from a series of 9 visual paired comparison tests. The novelty score is a measure of visual recognition memory for infants and has been shown to predict cognitive outcomes in childhood. This analysis will assess developmental trajectories for performance on this task across the first year of life (ages 5, 7, 10, and 13 months).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT 550 mg/day Choline
- DIETARY_SUPPLEMENT 25 mg/day Choline
Study Locations (1)
New York
- Cornell University - Ithaca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-12-13 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the registry record for NCT04987099 still lists
NCT04987099 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which 550 mg/day Choline is the first listed.
NCT04987099 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04987099 about?
NCT04987099 is a clinical study titled "Effects of Increased Maternal Choline Intake on Child Cognitive Development". The purpose of this study is to examine cognitive and affective outcomes in the offspring of women supplemented with choline vs. control during pregnancy.
What is the current status of trial NCT04987099?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-12-13. Estimated completion is 2024-12-31.
What conditions does trial NCT04987099 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT04987099?
The interventions under investigation include: 550 mg/day Choline (DIETARY_SUPPLEMENT), 25 mg/day Choline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04987099?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04987099 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04987099's enrollment target sits among peer trials
40 162nd of 191 higher than 27 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI